J2KBIO Co., Ltd. (KOSDAQ:420570)
7,810.00
-160.00 (-2.01%)
At close: Jun 5, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 45.67 billion as of June 8, 2026. Its market cap has decreased by -31.49% in one year.
Market Cap
45.67B
Enterprise Value
37.40B
Revenue
36.82B
Ranking
n/a
PE Ratio
11.30
Stock Price
7,810.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 45.67B, a decrease of -68.49%. That is a compound annual growth rate of -40.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 42.04B | -16.40% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Progen | 62.27B |
| IMGT Co.,Ltd. | 62.02B |
| Aptamer Sciences | 54.39B |
| Psomagen | 52.71B |
| Quratis | 51.41B |
| Shaperon | 50.40B |
| ADBiotech | 49.20B |
| HLB Pep | 46.51B |